sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 26, 2026

BofA sees August setting up as tough for stocks; dollar, gold favored

View original at seekingalpha.com
BofA sees August setting up as tough for stocks; dollar, gold favored [August 2026 Yellow Desk Calendar Among Office Supplies] spawns/iStock via Getty Images Investors heading into August may want to keep one hand on the steering wheel and the other near the hedge button…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Gold has historically strengthened while equities weakened and Treasury yields declined, making it one of the report's preferred seasonal hedges against stock market volatility.

    60% confidence
  • The Dow Jones Industrial Average has historically been the most resilient major stock index during August, while Hong Kong's Hang Seng Index has been the weakest performer; international equity markets generally have underperformed U.S. stocks during August.

    60% confidence
  • August has historically favored lower government bond yields, with the U.S. 30-year Treasury yield tending to decline, particularly in the second year of the presidential cycle.

    60% confidence
  • USD/ZAR is one of Bank of America's preferred seasonal trades, particularly if markets shift toward a risk-off environment.

    60% confidence
  • Bank of America has maintained a defensive market stance since late May, reinforced by the historical August-October seasonal weakness pattern.

    60% confidence
  • August through October has historically been the weakest rolling three-month period for the S&P 500, while the U.S. dollar, gold and bonds have often outperformed during the same window.

    60% confidence
  • Seasonal weakness in late summer isn't necessarily bearish for the longer term; it has often set the stage for one of the market's strongest periods, with November through January averaging a 3.54% gain for the S&P 500.

    60% confidence
  • The dollar has tended to perform particularly well against the British pound and Australian dollar in August, with the seasonal trend becoming even stronger during the second year of the U.S. presidential cycle.

    60% confidence
  • Energy is a notable exception to the broader risk-off backdrop, with the Bloomberg Energy Index historically gaining in August and crude oil prices tending to strengthen during the final third of the month.

    60% confidence
  • Seasonality is only one input among many for investors, but the historical evidence suggests August has often rewarded defensive positioning, stronger exposure to the U.S. dollar and gold, and caution toward equities until the market enters its historically stronger November-through-January period.

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,580 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
BofA sees August setting up as tough for stocks; dollar, gold favored — Source | Via News | pt.via.news